In AD context, APP overexpression and Aβ accumulation were found to disrupt EGF-R degradation in APP transgenic mice carrying the Swedish mutation, by inhibiting the UPS (Ubiquitin Proteasome System) [1]. This evidence concerns the gene APP and Alzheimer disease.